Related Experiment Videos
Reduction of epidermal growth factor receptor phosphorylation by activated Mullerian inhibiting substance is
M A Maggard1, E A Catlin, P L Hudson
1Pediatric Surgical Research Laboratories, Massachusetts General Hospital, Boston 02114, USA.
Abstract:
The carboxy-terminal domain of recombinant human Mullerian inhibiting substance (MIS) inhibits cellular proliferation in vitro and decreases epidermal growth factor (EGF)-dependent phosphorylation of the EGF receptor. Proteolytically cleaved and undissociated MIS is more potent than carboxy-terminal MIS alone, supporting a functional role for the amino-terminal region of the molecule. MIS does not block EGF binding to the EGF receptor, thus, MIS reduction of EGF receptor phosphorylation must occur distal to receptor ligand binding. The effect of proteolytically cleaved MIS on reduction of EGF receptor phosphorylation in membrane preparations is decreased by a specific phosphatase inhibitor, vanadate, thus implicating a membrane phosphatase in this MIS action at the EGF receptor.
Insights
Mullerian inhibiting substance (MIS) reduces cell growth by affecting the epidermal growth factor (EGF) receptor pathway. This action involves a membrane phosphatase, indicating a complex regulatory mechanism beyond simple ligand binding.
Area of Science:
- Cell Biology
- Molecular Endocrinology
- Signal Transduction
Background:
- Mullerian inhibiting substance (MIS) is a key regulator of sexual development.
- Epidermal growth factor (EGF) signaling pathways are crucial for cellular proliferation and differentiation.
- The precise mechanism by which MIS influences EGF receptor signaling remains incompletely understood.
Purpose of the Study:
- To investigate the role of different domains of MIS in inhibiting cellular proliferation.
- To elucidate the mechanism by which MIS affects EGF receptor phosphorylation.
- To identify potential molecular players involved in MIS-mediated modulation of EGF receptor signaling.
Main Methods:
- In vitro assays measuring cellular proliferation.
- Western blotting to assess EGF receptor phosphorylation.
- Analysis of MIS effects on membrane preparations in the presence of phosphatase inhibitors.
Main Results:
- The carboxy-terminal domain of MIS inhibits proliferation and EGF receptor phosphorylation.
- Proteolytically cleaved MIS exhibits greater potency, highlighting the importance of the amino-terminal region.
- MIS reduces EGF receptor phosphorylation downstream of ligand binding, implicating a membrane phosphatase.
Conclusions:
- MIS exerts anti-proliferative effects through modulation of the EGF receptor pathway.
- A membrane-associated phosphatase is likely involved in mediating MIS's inhibitory action on EGF receptor phosphorylation.
- The findings suggest a novel signaling mechanism for MIS in regulating cell growth.